Reprieve Cardiovascular Publishes FASTR Pilot Trial Findings in Journal of the American College of Cardiology: Heart Failure

Reprieve Cardiovascular Reports Published FASTR Pilot Study Results Supporting Potential New Approach for Acute Heart Failure Treatment Reprieve Cardiovascular, a development-stage medical technology company focused on transforming the treatment of…

Read MoreReprieve Cardiovascular Publishes FASTR Pilot Trial Findings in Journal of the American College of Cardiology: Heart Failure

Seek Labs Secures U.S. Patent for Novel Isothermal Molecular Amplification Technology Supporting Decentralized Diagnostic Testing

Seek Labs Secures U.S. Patent for Innovative Isothermal Amplification Technology Designed to Advance Decentralized Molecular Diagnostics Seek Labs, a private TechBio company focused on building programmable platforms to decode, program,…

Read MoreSeek Labs Secures U.S. Patent for Novel Isothermal Molecular Amplification Technology Supporting Decentralized Diagnostic Testing

Northwell’s Feinstein Institutes Researcher Alex C. Spyropoulos Named Prestigious Fulbright U.S. Scholar

Northwell’s Feinstein Institutes Researcher Alex C. Spyropoulos Receives Prestigious Fulbright U.S. Scholar Recognition Alex C. Spyropoulos, an internationally recognized authority in thrombosis and blood clotting disorders, has been awarded a…

Read MoreNorthwell’s Feinstein Institutes Researcher Alex C. Spyropoulos Named Prestigious Fulbright U.S. Scholar